Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Angiotensin-converting Enzyme Inhibitor (ACEi)
100%
Cohort Analysis
100%
Renin-angiotensin System Blockers
100%
COVID-19
100%
Open Science
100%
Monotherapy
80%
Angiotensin Receptor Blockers
80%
Hospital Admission
60%
Thiazides
60%
Calcium Channel Blockers
50%
Pneumonia
40%
Diuretics
40%
Combination Use
40%
Hazard Ratio
30%
COVID-19 Diagnosis
30%
Sepsis
20%
Drug Class
20%
Acute Kidney Injury
20%
Acute Respiratory Distress Syndrome
20%
COVID-19 Risk
20%
Primary Care
10%
No Significant Difference
10%
Data Warehouse
10%
Prediction Accuracy
10%
Spain
10%
Generalisability
10%
Relative Risk
10%
Propensity Score Methods
10%
Low Risk
10%
Patient Cohort
10%
Clinically Significant
10%
Combination Therapy
10%
Patients with Hypertension
10%
Antihypertensive Medication
10%
Patient Characteristics
10%
Pairwise Comparison
10%
Controlled Experiment
10%
Risk Difference
10%
Increased Vulnerability
10%
Negative Control
10%
Electronic Health Records
10%
Medical Center
10%
Combination of Therapies
10%
Negative Control Outcome
10%
Treatment Prediction
10%
Data-driven Approach
10%
Used Electronics
10%
Observational Medical Outcomes Partnership
10%
Columbia University
10%
COVID-19 Exposure
10%
Post-authorisation Studies
10%
Department of Veterans Affairs
10%
COVID-19 Inpatients
10%
COVID-19 Hospital
10%
Diuretic Combinations
10%
COVID-19 Hospital Admissions
10%
Approach Control
10%
SIDIAP
10%
Medicine and Dentistry
Cohort Analysis
100%
ACE Inhibitor
100%
Renin Angiotensin Aldosterone System
100%
COVID-19
100%
Monotherapy
80%
Angiotensin Receptor Antagonist
80%
Thiazide Diuretic Agent
60%
Calcium Channel Blocking Agent
50%
Diuretics
50%
Hazard Ratio
30%
COVID-19 Diagnosis
30%
Sepsis
20%
Antihypertensive Agent
20%
Acute Kidney Injury
20%
Acute Respiratory Distress Syndrome
20%
Observational Study
10%
Combination Therapy
10%
Primary Health Care
10%
Attributable Risk
10%
Patient Characteristics
10%
Patient with Hypertension
10%
Electronic Health Record
10%
Veterans Affairs
10%
Pharmacology, Toxicology and Pharmaceutical Science
Renin
100%
Angiotensin
100%
Dipeptidyl Carboxypeptidase Inhibitor
100%
Monotherapy
80%
Angiotensin Receptor Antagonist
80%
Thiazide Diuretic Agent
60%
Calcium Channel Blocker
50%
Diuretics
50%
Antihypertensive Agent
20%
Sepsis
20%
Acute Kidney Failure
20%
Adult Respiratory Distress Syndrome
20%
Combination Therapy
10%
Observational Study
10%